Browse by UCL people
Group by: Type | Date
Number of items: 83.
Article
Altomare, D;
Ferrari, C;
Caroli, A;
Galluzzi, S;
Prestia, A;
van der Flier, WM;
Ossenkoppele, R;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2019)
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
Journal of Neurology
, 266
pp. 2535-2545.
10.1007/s00415-019-09441-7.
|
|
Ashton, NJ;
Hye, A;
Rajkumar, AP;
Leuzy, A;
Snowden, S;
Suarez-Calvet, M;
Karikari, TK;
... Aarsland, D; + view all
(2020)
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.
Nature Reviews Neurology
, 16
(5)
pp. 265-284.
10.1038/s41582-020-0348-0.
|
|
Ashton, NJ;
Ide, M;
Scholl, M;
Blennow, K;
Lovestone, S;
Hye, A;
Zetterberg, H;
(2018)
No association of salivary total tau concentration with Alzheimer's disease.
Neurobiology of Aging
, 70
pp. 125-127.
10.1016/j.neurobiolaging.2018.06.014.
|
|
Ashton, NJ;
Janelidze, S;
Al Khleifat, A;
Leuzy, A;
van der Ende, EL;
Karikari, TK;
Benedet, AL;
... Hansson, O; + view all
(2021)
A multicentre validation study of the diagnostic value of plasma neurofilament light.
Nature Communications
, 12
(1)
, Article 3400. 10.1038/s41467-021-23620-z.
|
 |
|
Ashton, NJ;
Leuzy, A;
Lim, YM;
Troakes, C;
Hortobagyi, T;
Hoglund, K;
Aarsland, D;
... Hye, A; + view all
(2019)
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.
Acta Neuropathologica Communications
, 7
, Article 5. 10.1186/s40478-018-0649-3.
|
|
|
Ashton, NJ;
Nevado-Holgado, AJ;
Barber, IS;
Lynham, S;
Gupta, V;
Chatterjee, P;
Goozee, K;
... Hye, A; + view all
(2019)
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.
Science Advances
, 5
(2)
, Article eaau7220. 10.1126/sciadv.aau7220.
|
|
|
Ashton, NJ;
Pascoal, TA;
Karikari, TK;
Benedet, AL;
Lantero-Rodriguez, J;
Brinkmalm, G;
Snellman, A;
... Blennow, K; + view all
(2021)
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology.
Acta Neuropathologica
10.1007/s00401-021-02275-6.
(In press).
|
|
|
Ashton, NJ;
Schoell, M;
Heurling, K;
Gkanatsiou, E;
Portelius, E;
Hoeglund, K;
Brinkmalm, G;
... Zetterberg, H; + view all
(2018)
Update on biomarkers for amyloid pathology in Alzheimer's disease.
Biomarkers in Medicine
, 12
(7)
pp. 799-812.
10.2217/bmm-2017-0433.
|
|
Benedet, AL;
Leuzy, A;
Pascoal, TA;
Ashton, NJ;
Mathotaarachchi, S;
Savard, M;
Therriault, J;
... Alzheimer’s Disease Neuroimaging Initiative, .; + view all
(2020)
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Brain
, 143
(12)
pp. 3793-3804.
10.1093/brain/awaa342.
|
|
Benedet, AL;
Ashton, NJ;
Pascoal, TA;
Leuzy, A;
Mathotaarachchi, S;
Kang, MS;
Therriault, J;
... Neto, PR; + view all
(2019)
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 11
pp. 679-689.
10.1016/j.dadm.2019.08.002.
|
|
|
Bieger, Andrei;
Brum, Wagner S;
Borelli, Wyllians V;
Therriault, Joseph;
De Bastiani, Marco A;
Moreira, Amanda G;
Benedet, Andrea L;
... Alzheimer's Disease Neuroimaging Initiative; + view all
(2024)
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research.
Neurology
, 103
(5)
, Article e209753. 10.1212/WNL.0000000000209753.
|
|
Biel, Davina;
Luan, Ying;
Brendel, Matthias;
Hager, Paul;
Dewenter, Anna;
Moscoso, Alexis;
Svaldi, Diana Otero;
... Franzmeier, Nicolai; + view all
(2022)
Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer's disease.
Alzheimer's Research and Therapy
, 14
, Article 166. 10.1186/s13195-022-01105-5.
|
|
Bollack, Ariane;
Collij, Lyduine E;
García, David Vállez;
Shekari, Mahnaz;
Altomare, Daniele;
Payoux, Pierre;
Dubois, Bruno;
... AMYPAD, consortium; + view all
(2024)
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.
Alzheimer's & Dementia
10.1002/alz.13761.
(In press).
|
|
Chong, JR;
Ashton, NJ;
Karikari, TK;
Tanaka, T;
Scholl, M;
Zetterberg, H;
Blennow, K;
... Lai, MKP; + view all
(2021)
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
Journal of Neurology, Neurosurgery and Psychiatry
, 92
(11)
pp. 1231-1241.
10.1136/jnnp-2021-327370.
|
|
|
Costoya-Sánchez, Alejandro;
Moscoso, Alexis;
Silva-Rodríguez, Jesús;
Pontecorvo, Michael J;
Devous, Michael D;
Aguiar, Pablo;
Schöll, Michael;
... Alzheimer’s Disease Neuroimaging Initiative and the Harvard Agin; + view all
(2023)
Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity.
JAMA Neurology
10.1001/jamaneurol.2023.2560.
(In press).
|
|
Costoya-Sánchez, Alejandro;
Moscoso, Alexis;
Sobrino, Tomás;
Ruibal, Álvaro;
Grothe, Michel J;
Schöll, Michael;
Silva-Rodríguez, Jesús;
... Alzheimer's Disease Neuroimaging Initiative; + view all
(2024)
Partial volume correction in longitudinal tau PET studies: is it really needed?
NeuroImage
, 289
, Article 120537. 10.1016/j.neuroimage.2024.120537.
|
|
Cummings, Jeffrey L;
Teunissen, Charlotte E;
Fiske, Brian K;
Le Ber, Isabelle;
Wildsmith, Kristin R;
Schoell, Michael;
Dunn, Billy;
(2025)
Biomarker-guided decision making in clinical drug development for neurodegenerative disorders.
Nature Reviews Drug Discovery
, 24
pp. 589-609.
10.1038/s41573-025-01165-w.
|
|
Dahl, Kenneth;
Larsson, Stefan;
Bonn, Peter;
Wallin, Anita;
Itsenko, Oleksiy;
Scholl, Michael;
(2022)
Good manufacturing procedure production of [F-18] SynVesT-1, a radioligand for in vivo positron emission tomography imaging of synaptic vesicle glycoprotein 2A.
Journal of Labelled Compounds and Radiopharmaceuticals
, 65
(12)
pp. 315-322.
10.1002/jlcr.4002.
|
|
Dittrich, Anna;
Ashton, Nicholas J;
Zetterberg, Henrik;
Blennow, Kaj;
Simrén, Joel;
Geiger, Fiona;
Zettergren, Anna;
... Kern, Silke; + view all
(2022)
Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community-based sample of 70-year-olds.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 14
(1)
, Article e12295. 10.1002/dad2.12295.
|
 |
|
Ehrenberg, AJ;
Khatun, A;
Coomans, E;
Betts, MJ;
Capraro, F;
Thijssen, EH;
Senkevich, K;
... Paterson, RW; + view all
(2020)
Relevance of biomarkers across different neurodegenerative.
Alzheimer's Research & Therapy
, 12
, Article 56. 10.1186/s13195-020-00601-w.
|
|
|
Gebre, Robel K;
Rial, Alexis Moscoso;
Raghavan, Sheelakumari;
Wiste, Heather J;
Heeman, Fiona;
Costoya-Sánchez, Alejandro;
Schwarz, Christopher G;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2024)
Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure.
Journal of Nuclear Medicine
, 65
(9)
pp. 1473-1480.
10.2967/jnumed.123.267273.
|
|
Grothe, Michel J;
Moscoso, Alexis;
Silva-Rodríguez, Jesús;
Lange, Catharina;
Nho, Kwangsik;
Saykin, Andrew J;
Nelson, Peter T;
... Alzheimer's Disease Neuroimaging Initiative; + view all
(2022)
Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC.
Alzheimer's & Dementia
10.1002/alz.12763.
(In press).
|
|
Grothe, MJ;
Moscoso, A;
Ashton, NJ;
Karikari, TK;
Lantero-Rodriguez, J;
Snellman, A;
Zetterberg, H;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.
Neurology
10.1212/WNL.0000000000012513.
(In press).
|
|
|
Heurling, K;
Ashton, NJ;
Leuzy, A;
Zimmer, ER;
Blennow, K;
Zetterberg, H;
Eriksson, J;
... Schöll, M; + view all
(2019)
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies.
Molecular and Cellular Neuroscience
10.1016/j.mcn.2019.02.001.
(In press).
|
|
|
Ho, Natalie CW;
Bethlehem, Richard Ai;
Seidlitz, Jakob;
Nogovitsyn, Nikita;
Metzak, Paul;
Ballester, Pedro L;
Hassel, Stefanie;
... Dunlop, Katharine; + view all
(2024)
Atypical Brain Aging and Its Association With Working Memory Performance in Major Depressive Disorder.
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
, 9
(8)
pp. 786-799.
10.1016/j.bpsc.2024.04.008.
|
|
Jadhav, S;
Avila, J;
Schöll, M;
Kovacs, G;
Kövari, E;
Skrabana, R;
Evans, L;
... Zilka, N; + view all
(2019)
A walk through tau therapeutic strategies.
Acta Neuopathologica Communications
10.1186/s40478-019-0664-z.
|
|
|
Kanberg, Nelly;
Grahn, Anna;
Stentoft, Erika;
Bremell, Daniel;
Yilmaz, Aylin;
Studahl, Marie;
Nilsson, Staffan;
... Gisslén, Magnus; + view all
(2023)
COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
The Journal of Infectious Diseases
, Article jiad395. 10.1093/infdis/jiad395.
(In press).
|
|
|
Kanberg, Nelly;
Schöll, Michael;
Edén, Arvid;
Gisslén, Magnus;
(2024)
Reply to Finsterer.
The Journal of Infectious Diseases
, 229
(3)
pp. 920-921.
10.1093/infdis/jiad549.
|
|
Karikari, TK;
Benedet, AL;
Ashton, NJ;
Lantero Rodriguez, J;
Snellman, A;
Suárez-Calvet, M;
Saha-Chaudhuri, P;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.
Molecular Psychiatry
, 26
pp. 429-442.
10.1038/s41380-020-00923-z.
|
|
Karikari, TK;
Pascoal, TA;
Ashton, NJ;
Janelidze, S;
Benedet, AL;
Rodriguez, JL;
Chamoun, M;
... Blennow, K; + view all
(2020)
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
The Lancet Neurology
, 19
(5)
pp. 422-433.
10.1016/S1474-4422(20)30071-5.
|
|
Khatun, A;
Paterson, RW;
Schöll, M;
(2020)
University College London/University of Gothenburg PhD course "Biomarkers in neurodegenerative diseases" 2019—course organisation.
Alzheimer's Research & Therapy
, 12
, Article 18. 10.1186/s13195-020-0583-z.
|
|
|
Leuzy, Antoine;
Bollack, Ariane;
Pellegrino, Daniela;
Teunissen, Charlotte E;
La Joie, Renaud;
Rabinovici, Gil D;
Franzmeier, Nicolai;
... Farrar, Gill; + view all
(2025)
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.
Alzheimer's & Dementia
, 21
(3)
, Article e14528. 10.1002/alz.14528.
|
|
|
Leuzy, A;
Heurling, K;
Ashton, NJ;
Schöll, M;
Zimmer, ER;
(2018)
In vivo Detection of Alzheimer's Disease.
Yale Journal of Biology and Medicine
, 91
(3)
pp. 291-300.
|
|
|
Malzbender, K;
Barbarino, P;
Ferrell, P Barkman;
Bradshaw, A;
Brookes, AJ;
Diaz, C;
Van der Flier, WM;
... AD-RIDDLE Consortium; + view all
(2024)
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project.
The Journal of Prevention of Alzheimer's Disease
, 11
pp. 329-338.
10.14283/jpad.2024.32.
|
|
Mathies, FL;
Heeman, F;
Visser, PJ;
Den Braber, A;
Yaqub, M;
Klutmann, S;
Schöll, M;
... Buchert, R; + view all
(2024)
The Early Perfusion Image Is Useful to Support the Visual Interpretation of Brain Amyloid-PET With 18F-Flutemetamol in Borderline Cases.
Clinical Nuclear Medicine
, 49
(9)
pp. 838-846.
10.1097/RLU.0000000000005360.
|
|
Mattsson, N;
Eriksson, O;
Lindberg, O;
Scholl, M;
Lampinen, B;
Nilsson, M;
Insel, PS;
... Hansson, O; + view all
(2018)
Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.
Neurobiology of Aging
, 71
pp. 81-90.
10.1016/j.neurobiolaging.2018.07.003.
|
|
Mattsson, N;
Scholl, M;
Strandberg, O;
Smith, R;
Palmqvist, S;
Insel, PS;
Hgerstrom, D;
... Hansson, O; + view all
(2017)
F-18-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
EMBO Molecular Medicine
, 9
(9)
pp. 1212-1223.
10.15252/emmm.201707809.
|
|
Mattsson, N;
Smith, R;
Strandberg, O;
Palmqvist, S;
Scholl, M;
Insel, PS;
Hagerstrom, D;
... Hansson, O; + view all
(2018)
Comparing F-18-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.
Neurology
, 90
(5)
e388-e395.
10.1212/WNL.0000000000004887.
|
|
|
Moscoso, A;
Grothe, MJ;
Ashton, NJ;
Karikari, TK;
Rodriguez, JL;
Snellman, A;
Suárez-Calvet, M;
... Alzheimer’s Disease Neuroimaging Initiative, ,; + view all
(2021)
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
Brain
, 144
(1)
pp. 325-339.
10.1093/brain/awaa399.
|
|
|
Moscoso, A;
Grothe, MJ;
Schöll, M;
Alzheimer’s Disease Neuroimaging Initiative;
(2021)
Reduced [¹⁸F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.
European Journal of Nuclear Medicine and Molecular Imaging
, 48
pp. 2283-2294.
10.1007/s00259-021-05195-5.
|
|
Moscoso, A;
Heeman, F;
Raghavan, S;
Costoya-Sánchez, A;
Van Essen, M;
Mainta, I;
Camacho, V;
... Schöll, M; + view all
(2025)
Frequency and Clinical Outcomes Associated with Tau Positron Emission Tomography Positivity.
Journal of the American Medical Association (JAMA)
, 334
(3)
pp. 229-242.
10.1001/jama.2025.7817.
|
|
Moscoso, Alexis;
Wren, Melissa C;
Lashley, Tammaryn;
Arstad, Erik;
Murray, Melissa E;
Fox, Nick C;
Sander, Kerstin;
(2022)
Imaging tau pathology in Alzheimer's disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies.
Molecular Neurodegeneration
, 17
(1)
, Article 39. 10.1186/s13024-022-00543-x.
|
|
Moscoso, A;
Grothe, MJ;
Ashton, NJ;
Karikari, TK;
Lantero Rodríguez, J;
Snellman, A;
Suárez-Calvet, M;
... Alzheimer’s Disease Neuroimaging Initiative, .; + view all
(2021)
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
JAMA Neurology
, 78
(4)
pp. 396-406.
10.1001/jamaneurol.2020.4986.
|
|
|
Obrocki, P;
Khatun, A;
Ness, D;
Senkevich, K;
Hanrieder, J;
Capraro, F;
Mattsson, N;
... Zetterberg, H; + view all
(2020)
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
Alzheimer's Research & Therapy
, 12
(1)
, Article 20. 10.1186/s13195-020-00586-6.
|
|
|
Öhman, F;
Berron, D;
Papp, KV;
Kern, S;
Skoog, J;
Hadarsson Bodin, T;
Zettergren, A;
... Schöll, M; + view all
(2022)
Unsupervised mobile app-based cognitive testing in a population-based study of older adults born 1944.
Frontiers in Digital Health
, 4
, Article 933265. 10.3389/fdgth.2022.933265.
|
|
Ohman, Fredrik;
Eckerstrom, Marie;
Hessen, Erik;
Espenes, Jacob;
Eliassen, Ingvild V;
Lorentzen, Ingrid M;
Stalhammar, Jacob;
... Kirsebom, Bjorn-Eivind; + view all
(2023)
Demographically adjusted Rey-Osterrieth Complex Figure Test norms in a Swedish and Norwegian cohort aged 49-77?years and comparison with North American norms.
Scandinavian Journal of Psychology
10.1111/sjop.12966.
(In press).
|
|
|
Öhman, F;
Hassenstab, J;
Berron, D;
Schöll, M;
Papp, KV;
(2021)
Current advances in digital cognitive assessment for preclinical Alzheimer's disease.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12217. 10.1002/dad2.12217.
|
|
|
Palmqvist, S;
Scholl, M;
Strandberg, O;
Mattsson, N;
Stomrud, E;
Zetterberg, H;
Blennow, K;
... Hansson, O; + view all
(2017)
Earliest accumulation of beta-amyloid occurs within the default-mode network and concurrently affects brain connectivity.
Nature Communications
, 8
, Article 1214. 10.1038/s41467-017-01150-x.
|
|
|
Pascoal, TA;
Benedet, AL;
Ashton, NJ;
Kang, MS;
Therriault, J;
Chamoun, M;
Savard, M;
... Rosa-Neto, P; + view all
(2021)
Microglial activation and tau propagate jointly across Braak stages.
Nature Medicine
, 27
pp. 1592-1599.
10.1038/s41591-021-01456-w.
|
|
Polk, Sarah E;
Öhman, Fredrik;
Hassenstab, Jason;
König, Alexandra;
Papp, Kathryn V;
Schöll, Michael;
Berron, David;
(2025)
A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer’s disease.
npj Digital Medicine
, 8
, Article 266. 10.1038/s41746-025-01583-5.
|
|
|
Quint, WH;
Matečko-Burmann, I;
Schilcher, I;
Löffler, T;
Schöll, M;
Burmann, BM;
Vogels, T;
(2021)
Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.
Journal of Alzheimer's Disease
, 80
(2)
pp. 813-829.
10.3233/JAD-201334.
|
|
|
Rajan, MR;
Sotak, M;
Barrenas, F;
Shen, T;
Borkowski, K;
Ashton, NJ;
Biorserud, C;
... Borgeson, E; + view all
(2019)
Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum.
Scientific Reports
, 9
, Article 15385. 10.1038/s41598-019-51673-0.
|
|
|
Robert, A;
Schöll, M;
Vogels, T;
(2021)
Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.
International Journal of Molecular Sciences
, 22
(11)
, Article 6132. 10.3390/ijms22116132.
|
|
|
Roemer-Cassiano, Sebastian N;
Wagner, Fabian;
Evangelista, Lisa;
Rauchmann, Boris-Stephan;
Dehsarvi, Amir;
Steward, Anna;
Dewenter, Anna;
... Franzmeier, Nicolai; + view all
(2025)
Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer's disease.
Science Translational Medicine
, 17
(782)
, Article eadp2564. 10.1126/scitranslmed.adp2564.
|
|
|
Salami, A;
Adolfsson, R;
Andersson, M;
Blennow, K;
Lundquist, A;
Adolfsson, AN;
Schöll, M;
... Nyberg, L; + view all
(2021)
Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
Journal of Alzheimer's Disease
10.3233/JAD-210673.
(In press).
|
|
|
Salvado, G;
Grothe, MJ;
Groot, C;
Moscoso, A;
Scholl, M;
Gispert, JD;
Ossenkoppele, R;
(2021)
Differential associations of APOE-epsilon 2 and APOE-epsilon 4 alleles with PET-measured amyloid-beta and tau deposition in older individuals without dementia.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-021-05192-8.
(In press).
|
|
|
Schöll, Michael;
Verberk, Inge MW;
Del Campo, Marta;
Delaby, Constance;
Therriault, Joseph;
Chong, Joyce R;
Palmqvist, Sebastian;
(2024)
Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease.
The Lancet Healthy Longevity
, Article 100630. 10.1016/j.lanhl.2024.07.013.
(In press).
|
|
|
Schöll, M;
Maass, A;
(2020)
Does early cognitive decline require the presence of both tau and amyloid-β?
Brain
, 143
(1)
pp. 10-13.
10.1093/brain/awz399.
|
|
Schöll, M;
Maass, A;
Mattsson, N;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
Jagust, W;
(2018)
Biomarkers for tau pathology.
Molecular and Cellular Neuroscience
10.1016/j.mcn.2018.12.001.
(In press).
|
|
|
Schöll, M;
Ossenkoppele, R;
Strandberg, O;
Palmqvist, S;
Swedish BioFINDER study;
Jögi, J;
Ohlsson, T;
... Hansson, O; + view all
(2017)
Distinct ¹⁸F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease.
Brain
, 140
(9)
pp. 2286-2294.
10.1093/brain/awx171.
|
|
|
Shahim, Pashtun;
Zetterberg, Henrik;
Simren, Joel;
Ashton, Nicholas J;
Norato, Gina;
Schöll, Michael;
Tegner, Yelverton;
... Blennow, Kaj; + view all
(2022)
Association of Plasma Biomarker Levels With Their CSF Concentration and the Number and Severity of Concussions in Professional Athletes.
Neurology
, 99
(4)
e347-e354.
10.1212/WNL.0000000000200615.
|
|
Silva-Rodriguez, Jesus;
Labrador-Espinosa, Miguel A;
Moscoso, Alexis;
Scholl, Michael;
Mir, Pablo;
Grothe, Michel;
(2022)
Differential effects of tau stage, Lewy body pathology, and substantia nigra degeneration on FDG-PET patterns in clinical AD.
Journal of Nuclear Medicine
10.2967/jnumed.122.264213.
(In press).
|
|
Silva-Rodríguez, Jesús;
Labrador-Espinosa, Miguel A;
Moscoso, Alexis;
Schöll, Michael;
Mir, Pablo;
Grothe, Michel J;
Alzheimer’s Disease Neuroimaging, Initiative;
(2023)
Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
Brain
10.1093/brain/awad194.
(In press).
|
|
Silva-Rodríguez, Jesús;
Labrador-Espinosa, Miguel A;
Zhang, Linda;
Castro-Labrador, Sandra;
López-González, Francisco Javier;
Moscoso, Alexis;
Sánchez-Juan, Pascual;
... Grothe, Michel J; + view all
(2025)
The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients.
Brain
, Article awaf037. 10.1093/brain/awaf037.
(In press).
|
|
|
Simrén, J;
Leuzy, A;
Karikari, TK;
Hye, A;
Benedet, AL;
Lantero-Rodriguez, J;
Mattsson-Carlgren, N;
... Ashton, NJ; + view all
(2021)
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.
Alzheimer's & Dementia
, 17
(7)
pp. 1145-1156.
10.1002/alz.12283.
|
|
Sirindil, Fatih;
Maher, Sinead;
Schöll, Michael;
Sander, Kerstin;
Årstad, Erik;
(2022)
Oxidation-Cyclisation of Biphenyl Thioethers to Dibenzothiophenium Salts for Ultrarapid 18F-Labelling of PET Tracers.
International Journal of Molecular Sciences
, 23
(24)
, Article 15481. 10.3390/ijms232415481.
|
|
Smith, R;
Puschmann, A;
Schöll, M;
Ohlsson, T;
van Swieten, J;
Honer, M;
Englund, E;
(2016)
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.
Brain
, 139
(9)
pp. 2372-2379.
10.1093/brain/aww163.
|
|
|
Smith, R;
Scholl, M;
Leuzy, A;
Jogi, J;
Ohlsson, T;
Strandberg, O;
Hansson, O;
(2019)
Head-to-head comparison of tau positron emission tomography tracers [F-18]flortaucipir and [F-18]RO948.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-019-04496-0.
(In press).
|
|
|
Smith, R;
Schöll, M;
Londos, E;
Ohlsson, T;
Hansson, O;
(2018)
<sup>18</sup>F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies.
Scientific Reports
, 8
, Article 4717. 10.1038/s41598-018-23041-x.
|
|
|
Srikrishna, M;
Pereira, JB;
Heckemann, RA;
Volpe, G;
van Westen, D;
Zettergren, A;
Kern, S;
... Schöll, M; + view all
(2021)
Deep learning from MRI-derived labels enables automatic brain tissue classification on human brain CT.
Neuroimage
, 244
, Article 118606. 10.1016/j.neuroimage.2021.118606.
|
|
|
Srikrishna, Meera;
Heckemann, Rolf A;
Pereira, Joana B;
Volpe, Giovanni;
Zettergren, Anna;
Kern, Silke;
Westman, Eric;
... Scholl, Michael; + view all
(2022)
Comparison of Two-Dimensional- and Three-Dimensional-Based U-Net Architectures for Brain Tissue Classification in One-Dimensional Brain CT.
Frontiers in Computational Neuroscience
, 15
, Article 785244. 10.3389/fncom.2021.785244.
|
|
Tanaka, T;
Ruifen, JC;
Ying-Hwey, N;
Tan, CH;
Lim, CZJ;
Zhang, Y;
Stephenson, MC;
... Chen, C; + view all
(2021)
Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort.
European Journal of Neurology
, 28
(5)
pp. 1479-1489.
10.1111/ene.14704.
|
|
Thordardottir, S;
Rodriguez-Vieitez, E;
Almkvist, O;
Ferreira, D;
Saint-Aubert, L;
Kinhult-Stahlbom, A;
Thonberg, H;
... Graff, C; + view all
(2018)
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
Alzheimer's Research & Therapy
, 10
, Article 45. 10.1186/s13195-018-0374-y.
|
 |
|
Tjörnstrand, A;
Casar-Borota, O;
Heurling, K;
Schöll, M;
Gjertsson, P;
Himmelman, J;
Itsenko, O;
... Filipsson Nyström, H; + view all
(2020)
Lower 68 Ga-DOTATOC Uptake in Non-Functioning Pituitary Neuroendocrine Tumors Compared to Normal Pituitary Gland - a Proof-of-Concept Study.
Clinical Endocrinology
, 92
(3)
pp. 222-231.
10.1111/cen.14144.
|
|
Tjörnstrand, A;
Casar‐Borota, O;
Heurling, K;
Schöll, M;
Gjertsson, P;
Ragnarsson, O;
Filipsson Nyström, H;
(2021)
Pre‐ and postoperative 68Ga‐DOTATOC positron emission tomography for hormone‐secreting pituitary neuroendocrine tumors.
Clinical Endocrinology
, 94
(6)
pp. 956-967.
10.1111/cen.14425.
|
|
Vogels, T;
Leuzy, A;
Cicognola, C;
Ashton, NJ;
Smolek, T;
Novak, M;
Blennow, K;
... Schöll, M; + view all
(2019)
Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies.
Biological Psychiatry
10.1016/j.biopsych.2019.09.019.
(In press).
|
|
|
Yakoub, Yara;
Ashton, Nicholas J;
Strikwerda-Brown, Cherie;
Montoliu-Gaya, Laia;
Karikari, Thomas K;
Kac, Przemysław R;
Gonzalez-Ortiz, Fernando;
... PREVENT-AD Research Group; + view all
(2023)
Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease.
Alzheimer's & Dementia
10.1002/alz.13318.
(In press).
|
|
|
Yap, SY;
Frias, B;
Wren, MC;
Schöll, M;
Fox, NC;
Årstad, E;
Lashley, T;
(2021)
Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
Brain
10.1093/brain/awab120.
(In press).
|
|
|
Young, Peter;
Appel, Lieuwe;
Tolf, Andreas;
Kosmidis, Savvas;
Burman, Joachim;
Rieckmann, Anna;
Schoell, Michael;
(2023)
Image-derived input functions from dynamic O-15-water PET scans using penalised reconstruction.
EJNMMI Physics
, 10
, Article 15. 10.1186/s40658-023-00535-w.
|
|
|
Young, PNE;
Estarellas, M;
Coomans, E;
Srikrishna, M;
Beaumont, H;
Maass, A;
Venkataraman, AV;
... Schöll, M; + view all
(2020)
Imaging biomarkers in neurodegeneration: current and future practices.
Alzheimer's Research & Therapy
, 12
, Article 49. 10.1186/s13195-020-00612-7.
|
|
Proceedings paper
|
Alvén, J;
Heurling, K;
Smith, R;
Strandberg, O;
Schöll, M;
Hansson, O;
Kahl, F;
(2019)
A Deep Learning Approach to MR-less Spatial Normalization for Tau PET Images.
In: Shen, D and Liu, T and Peters, TM and Staib, LH and Essert, C and Zhou, S and Yap, PT and Khan, A, (eds.)
Medical Image Computing and Computer Assisted Intervention – MICCAI 2019: 22nd International Conference, Shenzhen, China, October 13–17, 2019, Proceedings, Part II.
(pp. pp. 355-363).
Springer: Cham, Switzerland.
|
Working / discussion paper
|
Moscoso, A;
Grothe, M;
Ashton, N;
Karikari, T;
Rodriguez, JL;
Snellman, A;
Suárez-Calvet, M;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2020)
Time course of phosphorylated tau181 in blood across the Alzheimer's disease spectrum.
MedRxiv: Cold Spring Harbor, NY, USA.
|
Conference item
|
Grothe, Michel J;
Silva-Rodríguez, Jesus;
Moscoso, Alexis;
Schöll, Michael;
(2023)
Clinical and biomarker characteristics of amnestic MCI patients exhibiting a temporo-limbic FDG-PET pattern suggestive of LATE.
Presented at: Alzheimer’s Association International Conference (AAIC®), Amsterdam, Netherlands.
|
